Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Fangliang, Lu"'
Autor:
Miao Huang, Bing Liu, Xiang Li, Nan Li, Xin Yang, Yaqi Wang, Shanyuan Zhang, Fangliang Lu, Shaolei Li, Shi Yan, Nan Wu
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundControversy surrounds the efficacy of adjuvant chemotherapy (ACT) in the treatment of stage I lung adenocarcinoma (LUAD). The objective of this study was to examine the impact of the maximum standardized uptake value (SUVmax) as measured by
Externí odkaz:
https://doaj.org/article/d3d18ddd2c924a83b15361b317f72481
Autor:
Junfeng Li, Jianjie Li, Huifeng Hao, Fangliang Lu, Jia Wang, Menglei Ma, Bo Jia, Minglei Zhuo, Jingjing Wang, Yujia Chi, Xiaoyu Zhai, Yuyan Wang, Meina Wu, Tongtong An, Jun Zhao, Fan Yang, Ziping Wang
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Early diagnosis of lung adenocarcinoma (LUAD), one of the most common types of lung cancer, is very important to improve the prognosis of patients. The current methods can’t meet the requirements of early diagnosis. There is a p
Externí odkaz:
https://doaj.org/article/4e503b5f1afd433b84022af7092f79b2
Autor:
Yuan Feng, Wei Sun, Jie Zhang, Yang Wang, Jinfeng Chen, Xinying Liu, Liang Wang, Shaolei Li, Chao Lv, Fangliang Lu, Jianzhi Zhang, Yang Hong, Shanshan Xiao, Tao Wang, Raymond Jiao, Ziping Wang, Liping Qi, Nan Li, Yue Yang, Dongmei Lin, Jian Fang
Publikováno v:
Thoracic Cancer, Vol 13, Iss 3, Pp 442-452 (2022)
Abstract Background A single‐agent of anti programmed cell death 1/programmed cell death ligand 1 (anti‐PD‐1/PD‐L1) therapy has been explored for resectable lung cancer before surgery. However, the effectiveness and safety of neoadjuvant prog
Externí odkaz:
https://doaj.org/article/fd177f47b56740bca7a3086875335027
Publikováno v:
Chinese Journal of Lung Cancer, Vol 24, Iss 4, Pp 299-304 (2021)
Background and objective Bronchopleural fistula (BPF) is one of the most serious and rare postoperative complications, especially the bronchial stump fistula after lobectomy/pneumonectomy. Common treatment options include conservative medical treatme
Externí odkaz:
https://doaj.org/article/aae36c8d8baf41779aaab684977cf4a0
Autor:
Jun NI, Miao HUANG, Li ZHANG, Nan WU, Chunxue BAI, Liang’an CHEN, Jun LIANG, Qian LIU, Jie WANG, Yilong WU, Fengchun ZHANG, Shuyang ZHANG, Chun CHEN, Jun CHEN, Wentao FANG, Shugeng GAO, Jian HU, Tao JIANG, Shanqing LI, Hecheng LI, Yongde LIAO, Yang LIU, Deruo LIU, Hongxu LIU, Jianyang LIU, Lunxu LIU, Mengzhao WANG, Changli WANG, Fan YANG, Yue YANG, Lanjun ZHANG, Xiuyi ZHI, Wenzhao ZHONG, Yuzhou GUAN, Xiaoxiao GUO, Chunxia HE, Shaolei LI, Yue LI, Naixin LIANG, Fangliang LU, Chao LV, Wei LV, Xiaoyan SI, Fengwei TAN, Hanping WANG, Jiangshan WANG, Shi YAN, Huaxia YANG, Huijuan ZHU, Junling ZHUANG, Minglei ZHUO
Publikováno v:
Chinese Journal of Lung Cancer, Vol 24, Iss 3, Pp 141-160 (2021)
Background and objective Perioperative treatment has become an increasingly important aspect of the management of patients with non-small cell lung cancer (NSCLC). Small-scale clinical studies performed in recent years have shown improvements in the
Externí odkaz:
https://doaj.org/article/463505d96c91469a815ec257e1195391
Publikováno v:
Chinese Journal of Lung Cancer, Vol 22, Iss 11, Pp 702-708 (2019)
Background and objective IIIa-N2 non-small cell lung cancer was significant different in survival, although N stage of lung cancer based on anatomic location of metastasis lymph node. Lymph node ratio considered of prognostic factor might be the eval
Externí odkaz:
https://doaj.org/article/da62888e96dc44bbb1e7045e1583d9bf
Autor:
Chao Lv, Wentao Fang, Nan Wu, Wenjie Jiao, Shidong Xu, Haitao Ma, Jia Wang, Rui Wang, Chunyu Ji, Shaolei Li, Yuzhao Wang, Shi Yan, Fangliang Lu, Yuquan Pei, Yinan Liu, Yue Yang
Publikováno v:
Lung Cancer. 178:151-156
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1393f30a1358dc84ad09c1f5d2a212db
https://doi.org/10.1016/j.lungcan.2023.02.011
https://doi.org/10.1016/j.lungcan.2023.02.011
Autor:
Yuan Feng, Wei Sun, Jie Zhang, Yang Wang, Jinfeng Chen, Xinying Liu, Liang Wang, Shaolei Li, Chao Lv, Fangliang Lu, Jianzhi Zhang, Yang Hong, Shanshan Xiao, Tao Wang, Raymond Jiao, Ziping Wang, Liping Qi, Nan Li, Yue Yang, Dongmei Lin, Jian Fang
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 13, Iss 3, Pp 442-452 (2022)
Thoracic Cancer, Vol 13, Iss 3, Pp 442-452 (2022)
Background A single‐agent of anti programmed cell death 1/programmed cell death ligand 1 (anti‐PD‐1/PD‐L1) therapy has been explored for resectable lung cancer before surgery. However, the effectiveness and safety of neoadjuvant programmed ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0063015f807154b3733ee39a6e4dcd14
https://doi.org/10.1111/1759-7714.14280
https://doi.org/10.1111/1759-7714.14280
Publikováno v:
J Thorac Dis
Background Although neoadjuvant chemotherapy could improve survival outcome in resectable non-small cell lung cancer (NSCLC), the efficacy of neoadjuvant targeted therapy is still unclear. Methods We retrospectively reviewed clinical records of stage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::260fc136b024c9847320db1525f138a4
https://doi.org/10.21037/jtd-20-1265
https://doi.org/10.21037/jtd-20-1265
Autor:
Fangliang Lu, Daisy Dandan Wang, Chao Lv, Peter Ping Lin, Shanyuan Zhang, Miao Huang, Yuanyuan Ma, Yue Yang, Shaolei Li
Publikováno v:
International Journal of General Medicine
Miao Huang,1,* Yuanyuan Ma,1,* Chao Lv,1 Shaolei Li,1 Fangliang Lu,1 Shanyuan Zhang,1 Daisy Dandan Wang,2 Peter Ping Lin,2 Yue Yang1 1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74cafd9b4ba1aa1eb120069a3efb912f
https://pubmed.ncbi.nlm.nih.gov/34703281
https://pubmed.ncbi.nlm.nih.gov/34703281